Clinical Significance of Plasma D-Dimer and Fibrinogen in Outcomes after Stroke: A Systematic Review and Meta-Analysis
Cerebrovascular Diseases · 2023 · 52 (3) · 318-343
DOI: 10.1159/000526476 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cerebrovascular Diseases, online erschienen am 24.10.2022. Verfasst von QiangJi Bao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Qinghai University, Xining, China. Hauptthemen laut MEDLINE: Stroke, Hemostatics. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 85 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
There is increasing evidence on the prognostic significance of D-dimer and fibrinolysis in stroke. However, the systematic analysis of their relationship with adverse outcomes after stroke is lacking. Herein, we comprehensively assessed the correlation of D-dimer and fibrinolysis with stroke outcomes through meta-analysis.
Methods
Studies for systematic literature review were retrieved from PubMed, EMBASE, and Cochrane Library databases. The association of D-dimer and fibrinolysis with outcomes of stroke patients was expressed as an odds ratio (OR) with 95% confidence intervals (95% CI).
Results
Totally, 52 studies comprising 21,473 stroke patients were included. The results showed that the high D-dimer level was significantly associated with peripheral venous thrombosis after stroke (OR 1.03, 95% CI 1.01–1.05), poor outcome (MRS >2) after stroke (OR 1.731, 95% CI 1.464–2.048), death after stroke (OR 2.367, 95% CI 1.737–3.224), stroke recurrence (OR 1.229, 95% CI 1.113–1.358), and early neurologic deterioration (NIHSS >4) (OR 1.791, 95% CI 1.117–2.870). Moreover, high fibrinogen level was significantly associated with poor outcome (MRS >2) after stroke (OR 1.650, 95% CI 1.314–2.071), death after stroke (OR 1.310, 95% CI 1.128–1.520), stroke recurrence (OR 1.228, 95% CI 1.166–1.422), early neurologic deterioration (NIHSS >4) (OR 2.381, 95% CI 1.156–4.904), and coronary events after stroke (OR 1.427, 95% CI 1.232–1.653).
Conclusion
Fibrinogen and D-dimer may be associated with adverse outcomes in patients with stroke, suggesting that they may serve as possible biomarkers for post-stroke adverse outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School, Qinghai University, Xining, China.
- Department of Science and Education, Qinghai Provincial People's Hospital, Xining, China.
- Department of Neurosurgery, Qinghai Provincial People's Hospital, Xining, China.
- Department of Nursing, Qinghai Institute of Health Sciences, Xining, China.
Zitieren
APA
Bao, Q., Zhang, J., Wu, X., Zhao, K., Guo, Y., Yang, M., & Du, X. (2023). Clinical Significance of Plasma D-Dimer and Fibrinogen in Outcomes after Stroke: A Systematic Review and Meta-Analysis. Cerebrovascular Diseases, 52(3), 318-343. https://doi.org/10.1159/000526476
Vancouver
Bao Q, Zhang J, Wu X, Zhao K, Guo Y, Yang M, et al. Clinical Significance of Plasma D-Dimer and Fibrinogen in Outcomes after Stroke: A Systematic Review and Meta-Analysis. Cerebrovascular Diseases. 2023;52(3):318-343. doi:10.1159/000526476
BibTeX
@article{Bao2023,
author = {Bao, QiangJi and Zhang, JingNi and Wu, XinTing and Zhao, Kai and Guo, Yu and Yang, MingFei and Du, XiaoFeng},
title = {Clinical Significance of Plasma D-Dimer and Fibrinogen in Outcomes after Stroke: A Systematic Review and Meta-Analysis},
journal = {Cerebrovascular Diseases},
year = {2023},
volume = {52},
number = {3},
pages = {318--343},
doi = {10.1159/000526476}
}
EUVIMED